TRCT
MBIO icon

Tower Research Capital (TRC)’s Mustang Bio MBIO Stock Holding History

Tower Research Capital (TRC)’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33K Hold
1,895
– – ﹤0.01% 4840
2026
Q1 		$1.38K Buy
1,895
+959
+102% +$903 ﹤0.01% 4676
2025
Q4 		$918 Sell
936
-396
-30% -$523 ﹤0.01% 4796
2025
Q3 		$2.02K Sell
1,332
-2,646
-67% -$4.7K ﹤0.01% 4693
2025
Q2 		$3.8K Buy
3,978
+2,078
+109% +$2.51K ﹤0.01% 4435
2025
Q1 		$2.38K Buy
1,900
+1,684
+780% +$6.42K ﹤0.01% 4556
2024
Q4 		$1.91K Sell
216
-4
-2% -$44 ﹤0.01% 4939
2024
Q3 		$2.59K Sell
220
-146
-40% -$2.41K ﹤0.01% 4965
2024
Q2 		$8.66K Buy
366
+207
+130% +$3.94K ﹤0.01% 4319
2024
Q1 		$8.27K Buy
159
+32
+25% +$2.03K ﹤0.01% 4052
2023
Q4 		$8.6K Buy
127
+109
+606% +$8.65K ﹤0.01% 4491
2023
Q3 		$1.85K Buy
18
+11
+157% +$2.13K ﹤0.01% 5259
2023
Q2 		$2.19K Sell
7
-28
-80% -$7.03K ﹤0.01% 5233
2023
Q1 		$10K Sell
35
-13
-27% -$5.33K ﹤0.01% 4371
2022
Q4 		$14K Buy
48
+20
+71% +$6.83K ﹤0.01% 3516
2022
Q3 		$10K Buy
28
+7
+33% +$3.24K ﹤0.01% 4545
2022
Q2 		$9K Sell
21
-10
-32% -$5.54K ﹤0.01% 4572
2022
Q1 		$24K Buy
31
+2
+7% +$1.64K ﹤0.01% 3369
2021
Q4 		$36K Buy
29
+11
+61% +$17.8K ﹤0.01% 3049
2021
Q3 		$36K Sell
18
-14
-44% -$30.1K ﹤0.01% 3223
2021
Q2 		$79K Sell
32
-7
-18% -$17.2K ﹤0.01% 2618
2021
Q1 		$97K Buy
39
+29
+290% +$86.2K ﹤0.01% 2608
2020
Q4 		$30K Sell
10
-34
-77% -$81.3K ﹤0.01% 3567
2020
Q3 		$104K Buy
44
+36
+450% +$88.7K ﹤0.01% 3118
2020
Q2 		$20K Buy
8
+3
+60% +$7.01K ﹤0.01% 3680
2020
Q1 		$9K Buy
+5
New +$12.8K ﹤0.01% 2077
2019
Q4 		– Sell
-13
Closed -$29.8K – 3280
2019
Q3 		$32K Buy
+13
New +$35.6K ﹤0.01% 2147
2019
Q2 		– Sell
-3
Closed -$7K – 4034
2019
Q1 		$7K Sell
3
-3
-50% -$8.5K ﹤0.01% 2877
2018
Q4 		$13K Sell
6
-3
-33% -$9.12K ﹤0.01% 2262
2018
Q3 		$42K Buy
+9
New +$45K ﹤0.01% 1867
2018
Q2 		– Hold
0
– – – 3340

Other funds holding MBIO

KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
CFO4Life Group Coppell, Texas $743M AUM 25.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Tower Research Capital (TRC)'s MBIO Position: Q2 2026 in Review

Tower Research Capital (TRC) held its Mustang Bio (MBIO) position steady in Q2 2026 at 1,895 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #4840.

Tower Research Capital (TRC) first reported a position in MBIO in Q3 2018 and has held it in 30 quarters since. The position peaked at $104K in Q3 2020. 23 funds tracked by Wall St. Rank hold MBIO as of Q2 2026.

  • Tower Research Capital (TRC) held 1,895 shares of Mustang Bio worth $1.33K as of Q2 2026.
  • Tower Research Capital (TRC) left its Mustang Bio share count unchanged in Q2 2026.
  • Mustang Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4840 holding.
  • Tower Research Capital (TRC) first reported a position in Mustang Bio in Q3 2018 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s Mustang Bio position peaked at $104K in Q3 2020.
  • 23 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.